EQT is a leading global private equity group with approximately EUR 29 billion in raised capital. EQT has portfolio companies in Europe, Asia and the US with total sales of more than EUR 17 billion and approximately 140,000 employees. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. Since March 2016, LimaCorporate is owned by EQT with the family office of a successful orthopedics entrepreneur as co-investor.
Industrialist Advisory Board Members
MICHEL ORSINGER, Chairman of the Board
Michel Orsinger held the position of Worldwide Chairman DePuy Synthes Companies at Johnson & Johnson ("J&J") from 2012 to 2015. He was also a member of J&J's Global Management Team. Michel Orsinger joined Johnson & Johnson following the sale of Synthes Inc. for $20 billion, the largest acquisition ever realized by Johnson & Johnson. Subsequently, Michel Orsinger established the world's largest and most comprehensive orthopedic company. Prior to his leadership role at J&J, Mr. Orsinger was COO and CEO of Synthes Inc for eight years, and spent eleven years with Novartis.
Today, Michel Orsinger is an investor as well as board member of several start-up companies and an advisor to EQT. Moreover, he joined the Board of Takeda in 2016, the largest Japanese and Asian pharmaceutical company.
Doug Kohrs, Board Member
Doug Kohrs is an industry veteran with more than 25 years of experience in the orthopaedic sector having started his career in 1982 in the space.
From 2006 to 2012, he was CEO and president of Tornier, the US-based orthopaedic company, where he was key in developing Tornier into one of the top orthopaedic companies, specifically for extremities implants. Before his tenure as CEO of Tornier, Mr. Kohrs was CEO of American Medical Systems (1999-2006) and held several roles at Zimmer and Sulzer Spine Tech.
Mr. Kohrs is now focused on non-executive roles in the US with specific focus on the healthcare and orthopaedic space.
Bruno A. Melzi, Board Member
Mr. Melzi joined Zimmer Inc. in 1990 as Managing Director for Italy, from 1997 to 2000 he served as Vice President Europe to become President for EMEA from 2000 to 2003. From this year till 2005 he was Chairman International EMEA & Japan with the direct report of finance, human resources, legal and communications functions. From 2005 to 2013 Mr. Melzi was Chairman for Zimmer EMEA. Mr. Melzi also played a key role in the integration of the international businesses of Zimmer Holdings Inc. and Centerpulse. Mr. Melzi has over 40 years of experience in the orthopaedics and medical device industry, working also with Johnson & Johnson Italy and Smith & Nephew; he holds a degree in Law from the Pavia University.
Eric Lohrer, Board Member
Eric Lohrer represents our co-investor who successfully built one of the largest global orthopedics companies. From 2004-2014, Eric held several management roles at Synthes, respectively Johnson & Johnson's DePuy Synthes, focusing on orthopaedic devices in the US, Asia and Europe. Prior to Synthes he worked for Credit Suisse First Boston in New York.
Massimo Rossi, Board Member
Massimo Rossi has a longstanding relationship with EQT since 1994 and is a member of the EQT Investment Advisory Committee.
He acted as Board Member and Chairman to the Board of several EQT portfolio companies.
Moreover, Massimo was the CEO and president of Swedish Match from 1988 to 1993. In 1995 Mr. Rossi was granted, by The King of Sweden, the order of "Knight of the Northern Star" for outstanding contribution to the Swedish industry as well as to humanitarian commitments.
Michael Bauer, Board Member
Michael Bauer is a partner at EQT Partners AG. He is Head of EQT Partners' Equity team in Switzerland and the Deputy Head of EQT's Healthcare Practice.